BRIEF-Dicerna & Roche To Develop DCR-HBVS For Treatment Of Chronic Hepatitis B Virus Infection [Reuters]
Dicerna Pharmaceuticals, Inc. (DRNA)
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dicerna.com
Company Research
Source: Reuters
BRIEF-Dicerna & Roche To Develop DCR-HBVS For Treatment Of Chronic Hepatitis B Virus Infection - Reuters 1 Min Read Oct 31 (Reuters) - Dicerna Pharmaceuticals Inc: * DICERNA ENTERS AGREEMENT WITH ROCHE TO DEVELOP AND COMMERCIALIZE DCR-HBVS FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION * DICERNA PHARMACEUTICALS - ROCHE TO GAIN WORLDWIDE LICENSE TO CO’S NOVEL RNAI THERAPY CURRENTLY IN PHASE 1 * DICERNA PHARMACEUTICALS - TO RECEIVE $200 MILLION UP FRONT PLUS UP TO $1.47 BILLION IN POTENTIAL MILESTONE PAYMENTS RELATED TO DCR-HBVS * DICERNA PHARMACEUTICALS - CO, ROCHE TO COLLABORATE ON RESEARCH AND DEVELOPMENT OF MORE THERAPIES TARGETING MULTIPLE HUMAN, VIRAL GENES IMPLICATED IN CHRONIC HBV INFECTION * DICERNA PHARMACEUTICALS - TO RETAIN OPTION TO CO-FUND PIVOTAL DEVELOPMENT OF DCR-HBVS WORLDWIDE & CO-PROMOTE IN U.S. WITH ENHANCED ROYALTIES Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchan
Show less
Read more
Impact Snapshot
Event Time:
DRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRNA alerts
High impacting Dicerna Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics